BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2016
At a glance
- Drugs Nesiritide (Primary)
- Indications Cardiovascular disorders; Diabetes mellitus; Obesity
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 27 Oct 2015 Planned End Date changed from 1 Dec 2015 Jun 2008 to 1 Jun 2018 as reported by ClinicalTrials.gov.
- 24 Jul 2014 Planned End Date changed from 1 Jun 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.